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LysophosphatidylcholinePhospholipase A2 (PLA2) not only plays a role in the membrane vesiculation system but also mediates
membrane-raft budding and ﬁssion in artiﬁcial giant liposomes. This study aimed to demonstrate the same
effects in living cells. Differentiated Caco-2 cells were cultured on ﬁlter membranes. MDCK cells were
challenged with Inﬂuenza virus. The MDCK cultures were harvested for virus titration with a plaque assay.
Alkaline phosphatase (ALP), a membrane-raft associated glycosylphosphatidylinositol (GPI)-anchored
protein, was 70% released by adding 0.2 mmol/l lysophosphatidylcholine, which was abolished by
treatment with a membrane-raft disrupter, methyl-β-cyclodextrin. Activation of calcium-independent PLA2
(iPLA2) by brefeldin A increased the apical release of ALP by approximately 1.5-fold (pb0.01), which was
blocked by PLA2 inhibitor bromoenol lactone (BEL). BEL also reduced Inﬂuenza virus production into the
media (b10%) in the MDCK culture. These results suggest that cells utilize inverted corn-shaped
lysophospholipids generated by PLA2 to modulate plasma membrane structure and assist the budding of
raft-associated plasma membrane particles, which virus utilizes for its budding. Brush borders are enriched
with membrane-rafts and undergo rapid turnover; thus, PLA2 may be involved in the regulatory mechanism
in membrane dynamism. Further, iPLA2 may provide a therapeutic target for viral infections.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Membrane-rafts are cholesterol/sphingolipid-rich liquid-ordered
phase membrane that endows plasma membrane with a physically
unique aspect and heterogeneity. Certain membrane proteins, e.g.,
glycosylphosphatidylinositol (GPI)-anchored proteins, are exclusively
sorted into membrane-rafts, providing specialized biologically func-
tional platforms for processes such as signal transduction, invagina-
tion for endocytosis, and pathogen entry and exit [1]. For example,kotriene D4; BFA, brefeldin A;
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ll rights reserved.certain viruses utilize membrane-rafts as pits for virion assembly and
budding from the plasma membrane [2].
Brush borders are specialized apical cell surface domains of
epithelial cells, which are enriched with stable membrane-rafts [3].
Membrane-rafts in brush borders are considered to recruit digestive
enzymes to fulﬁll high-throughput digestive/absorptive functions.
Membrane-rafts in brush borders also supply vesicles for endocytosis
and subsequent intracellular transport. In the duodenal lumen,
intestinal epithelial cells are exposed to abundant lysophosphatidyl-
choline (lysoPC; 2–4 mmol/l at postprandial period) produced by the
digestion of biliary phosphatidylcholine with pancreatic PLA2 [4]. We
previously observed that alkaline phosphatase (ALP), a membrane-
raft associated GPI-anchored intestinal ectoenzyme, was released in
the presence of lysoPC in vitro and in vivo, suggesting that lysoPC
mediates membrane-raft budding and ﬁssion in the small intestine
[5], the same as has been observed in artiﬁcial bilayer membranes [6].
The release was not due to cell lysis by lysoPC, because fully
differentiated Caco-2 cells showed no cell lysis with exposure to
lysoPC as well as the enterocytes in the small intestine [5].
Evidence exists that ﬁssion is directly linked to changes in the
composition of the lipid bilayer, suggesting that the physiological
Fig. 1. Lysophosphatidylcholine releases brush border alkaline phosphatase. (A) LysoPC
was added to the apical medium at the indicated concentrations and incubated for 2 h.
The cells (open triangle) and the apical media (open circle) were assayed for ALP
activity. Closed rectangle, total ALP activity of the culture. Data are shown as mean and
S.E.M. of triplicate assays. (B) Lysophospholipids mediate the release of ALP.
Phospholipids, lysophospholipids, and lysoPC-related compounds were tested for ALP
release at 0.2 mM. PC, phosphatidylcholine; PI, phosphatidylinositol; PE, phosphati-
dylethanolamine; SM, sphingomyelin. Data are shown as mean and S.E.M. of triplicate
assays.
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lipid modifying enzyme, cytoplasmic phospholipase A2 (PLA2), and
especially calcium-independent PLA2 (iPLA2), is implicated in various
intracellular membrane trafﬁcking events, such as the formation of
membrane tubules from the Golgi complex and endosomes, mem-
brane tubules from the Golgi complex and endosomes, andmembrane
fusion events in the secretory and endocytic pathways [8]. iPLA2
generates inverted corn-shaped lysophospholipids that alter mem-
brane curvature and the intrinsic properties of multicomponent
membranes and modulate the line tension at the raft boundaries,
which is considered to induce vesicle ﬁssion. In fact, studies with
artiﬁcial giant liposomes showed that PLA2 also mediated membrane-
raft budding and ﬁssion [9,10], while there are no reports on the role
of iPLA2 for the modulation of plasma membrane of living cells. The
situation in biological membranes is very different from that in
artiﬁcial bilayer membranes [11]. Thus, demonstrating the involve-
ment of iPLA2 in modulation of the plasma membrane in living cells
could help in the further understanding of membrane dynamism in
raft-mediated endocytosis or budding, including virus entry and exit,
and regulatory mechanisms for plasma membrane composition and
functions.
The present study examinedwhether ALP released by lysoPC relies
on membrane-raft domains or not, the involvement of endogenous
PLA2 in the release of ALP, and the effect of PLA2 inhibitors on the
budding of Inﬂuenza A virus from infected MDCK cells.
2. Materials and methods
2.1. Reagents
Phospholipids and methyl-β-cyclodextrin (MβCD), a membrane-
raft disrupter, and all other chemicals were obtained from Sigma (St
Louis, MO, USA) unless otherwise indicated. Leukotriene D4 was from
Cayman Chemical (Ann Arbor, MI, USA); a calcium ionophore,
A23187, was from Sigma; a calcium chelator, BAPTA/AM was from
Nacalai Tesque (Kyoto, Japan). Glycyl-L-phenylalanine 2-naphthyla-
mide (GPN), a lysosome-disrupting cathepsin C substrate, was from
Sigma. Inhibitors used in this study were as follows: Golgi trafﬁc
inhibitors, monensin (Alexis Corp., Lausen, Switzerland) and brefeldin
A (BFA; Fermenteck Ltd., Jerusalem, Israel); glycoprotein synthesis
inhibitor, tunicamycin (LKT Lab Inc., St. Paul, MN, USA); phospholi-
pase D inhibitor, 1,10-phenanthroline (Nacalai Tesque); Ca-depen-
dent and Ca-independent phospholipase A2 (cPLA2 and iPLA2)
inhibitor, methyl arachidonyl ﬂuorophosphonate (MAFP; Cayman);
iPLA2 inhibitor, bromoenol lactone (BEL, Cayman).
2.2. Cell culture
Caco-2 cells were obtained from Dr Terrence Riehl (Washington
University School of Medicine). This subclonewas originally cloned by
F. Jeffrey Field (Department of Internal Medicine, University of Iowa,
USA), and it was reported that the subclone showed a marked
induction of alkaline phosphatase expression at postconﬂuence [12].
Cell culture reagents were purchased from Invitrogen (Tokyo, Japan)
and microporous PET membrane inserts (1 μm pore size, 23 mm
diameter) from BD Biosciences (NJ, USA). Caco-2 cells (between
passages 35 and 50 of Caco-2 cells after subcloning) were plated at a
density of 5×104 cells per cm2 ﬁlter and grown under a humidiﬁed
atmosphere containing 5% CO2 at 37 °C in Dulbecco's modiﬁed
essential medium containing 25 mmol/l glucose, GlutaMAX™
(Product No. 10564-011, Invitrogen), and 20% heat-inactivated FCS.
Cells were grown to conﬂuence for a week and then cultured in
asymmetric conditions, with the same medium but containing
5 mmol/l glucose in the upper compartment and the medium
containing 20% FCS in the lower compartment for 3 days, and
subsequently the cells were cultured in medium containing 1% ITS-G(Invitrogen) for 4 days as the basolateral medium. Media were
changed every day. Penicillin/streptomycin (100 IU/ml and 100 μg/
ml, respectively) and 1% nonessential amino acids were added to all
media.
MDCK cells (JCRB9029) were obtained from JCRB cell bank
(Ibaraki, Japan) and maintained in Dulbecco's modiﬁed essential
medium containing 5mmol/l glucose and GlutaMAX™ supplemented
with 10% FCS.
2.3. Enzyme assays
The enzyme assays used 1 mol/l ethylaminoethanol buffer, pH
10.5, containing 15 mmol/l p-nitrophenyl-phosphate and 5 mmol/
l MgCl2 as a substrate buffer for ALP assays, which were performed at
37 °C for 5 min [13]. ALP activity in the medium was expressed as mU
secreted per square centimeter of cell monolayer during the indicated
period (mU/cm2) or relative changes versus untreated control (fold).
Cell surface ALP activity was estimated as described previously [14].
Brieﬂy, the cells on the ﬁlter were ﬁxed with 1% glutaraldehyde in
10mmol/l Tris–HCl buffer, pH 8.0, for 15min at 4 °C, andwashedwith
cold Tris-buffered saline. Then, the surface ALP activity was detected
at 37 °C using 200 mmol/l carbonate buffer, pH 10.5, containing
10 mmol/l p-nitrophenyl-phosphate and 5 mmol/l MgCl2 as a
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Detection Kit, Clontech Laboratories Inc., Palo Alto, CA, USA). For MTT
assay, a commercial kit (Cell Proliferation Colormetric Assay Kit,
Promega, Madison, WI, USA) was used.
2.4. Centrifugational separation of released alkaline phosphatase
ALP in culture supernatants can exist as membrane-free, mem-
brane-bound form, or in cell debris. To separate these forms, culture
supernatants after 2 h incubation were ﬁrst centrifuged at 1500 ×g for
5 min to remove cell debris. The resulting supernatants were
subsequently centrifuged at 130,000 ×g for 30 min to precipitate
membrane-bound ALP [15]. ALP activity in each fractionwas shown as
% of that of respective original supernatants.
2.5. Virus infection and TCID50 (Tissue Culture Infections Dose 50) assays
Inﬂuenza A virus (N1H1; ATCC, VR544) was expanded in the
MDCK cultures as described previously [16]. MDCK cells were seeded
into 96-well plates, incubated overnight, and challenged with
Inﬂuenza A virus at a virus concentration of 0.1 multiplicity of
infection (MOI) for 1 h. The cells were then incubated for 3 days with
fresh medium containing 2 μg/ml of acetylated trypsin. The culture
supernatant was harvested and the virus titer was determined by
TCID50 assay [16].Fig. 2. ALP released by lysoPC is membrane-bound. (A) The culture supernatants treated w
materials were separated by differential centrifugation as described in “Materials and m
membrane-bound and membrane-free forms of ALP and cell debris; “Cell removed”, memb
forms of ALP. Data were shown as % versus ALP activity of total (uncentrifuged supernatants)
shortens the brush borders of Caco-2 cells. Electron micrographs of the brush borders of diff
0.5 μm; representative of n=5 in each group. (B) Statistical comparison of the length of m2.6. Electron microscopy
Caco-2 cell monolayers were ﬁxed in 2.5% glutaraldehyde for 2 h,
and post-ﬁxed in a 1% OsO4 solution buffered with Sorenson's
phosphate at pH 7.4. Then, the cells were rapidly dehydrated in
alcohol and embedded in Epon 812. Thin sections of representative
areas were then examined by electron microscopy. Caco-2 cells
visualized (n=5 per experiment) at ×125,000 magniﬁcation were
scanned and the length of the brush border was measured.
2.7. Statistical analysis
Data are shown as means±SEM of triplicate assays unless
indicated. For parametric data, means were compared using Student's
t-test. Mann–Whitney U test was used for nonparametric data. The
statistical analyseswere performed using Statview version 5.0 forWin
software (SAS Institute).
3. Results
3.1. Alkaline phosphatase release by lysophosphatidylcholine
We previously observed that lysoPC mediates the release of
intestinal brush border ALP [5]. In the present study, we found that
lysoPC released ALP in a dose-dependent manner, accompanying the
corresponding loss of cellular ALP activity (Fig. 1A). Basal LDH releaseith or without 0.2 mmol/l lysoPC for 2 h were used. The cell debris and membranous
ethods”. The resulting supernatants were assayed for ALP activity. “Total” includes
rane-bound and membrane-free forms of ALP; “Membrane removed”, membrane-free
. Data are shown as mean and S.E.M. of triplicate assays. (B–D) Lysophosphatidylcholine
erentiated Caco-2 cells with (D) or without (C) treatment with 0.2 mmol/l lysoPC. Bar,
icrovilli of the cells (mean and S.E.M., n=5). ⁎, pb0.05.
Fig. 3. (A) MβCD inhibits lysophosphatidylcholine-mediated alkaline phosphatase
release. Differentiated Caco-2 cells were incubated with 0.2 mmol/l lysoPC for 2 h and
inhibitors were added before lysoPC at concentrations of 2% MβCD (w/v) (30 min),
200 μmol/l glycyl-L-phenylalanine 2-naphthylamide (2 h), 100 μmol/l 1,10-phenantro-
line (10 min), 5 μmol/l monensin (2 h), 3 μg/ml tunicamycin (2 h), and 2 μg/ml
brefeldin A (2 h). The time in parenthesis indicates the preincubation period with each
of the drugs tested. Data are shown as mean and S.E.M. of triplicate assays. (B) MβCD
prevents the loss of brush border ALP. The addition of lysoPC reduced the surface ALP
activity about by half, but the reduction was completely abolished by adding MβCD.
Data are shown as mean and S.E.M. of triplicate assays.
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with exposure to 0.2 and 2 mmol/l lysoPC, respectively (Ref);
however, the release of ALP was unlikely due to cell lysis by lysoPC,
because even 0.2 mmol/l lysoPC generatedmore than 30% ALP release
[5]. LysoPC and lysosphingomyelin effectively released ALP (approx-
imately 13–14-fold vs. untreated control) among other lysopho-
spholipids, phospholipids, and cholines tested (Fig. 1B).
Lysophosphatidylinositol was the third in terms of releasing ability,
showing 7- to 8-fold increase, but other lipids showed no or weak
releasing effects.
3.2. Released alkaline phosphatase is membrane-bound
Differentiated Caco-2 cells secrete ALP mainly as a membrane-free
form (Fig. 2A) in the absence of lysoPC. In the presence of lysoPC,
more than 70% of ALP released was in the membrane-bound form
after removing cell debris. The addition of lysoPC exhibited no
appreciable damage to the microvillus membrane compared with the
control (Fig. 2C, D), except for the shortening of microvillus length by
about 40% (Fig. 2B). This effect was consistent with the ﬁndings by
Hansen et al. [17] who observed similar shortening of microvilli in
organ cultured mouse intestinal explants by adding a pancreatin-
predigested corn oil/bile emulsion, which contains lysoPC as a result
of the digestion of PC by pancreatic PLA2.
3.3. Released alkaline phosphatase originated from polarized Caco-2
apical membrane
To identify other sources for increased ALP release in Caco-2 cells,
various inhibitors were added when the cells were exposed to lysoPC.
Only MβCD, a membrane-raft disrupter, blocked the release by 70%
among the inhibitors tested, indicating that the increased release of
ALPmostly originated from the cell surface and that neither lysosomal
exocytosis nor stimulation of membrane trafﬁcking lysoPC was likely
(Fig. 3A). No inhibitory effect on ALP activity assay was observed with
MβCD (data not shown). The surface ALP activity was measured
directly after ﬁxing the cells and conﬁrmed that the loss of cell surface
ALP activity was blocked completely by MβCD (Fig. 3B). Enzymatic
release of ALP by phospholipase Dwas a possibility, but the addition of
1,10-phennanthroline, an inhibitor of phospholipase D, did not
attenuate the release. ALP exists in the lysosome and the release of
enzymes from lysosomal endocytosis by adding lysoPC was suggested
[18], but Gly-Phe-naphthylamide, which induces lysosomal lysis, did
not reduce the increase of ALP in the apical medium.
3.4. Increased alkaline phosphatase release via activation of
phospholipase A2 activity
Cytoplasmic PLA2 generates lysoPC endogenously, which might
regulate membrane-raft budding and ﬁssion at the plasma mem-
brane. To examine this hypothesis, known cytosolic PLA2 activators
(A23187 and leukotriene D4 for Ca-dependent A2 [19], and BFA for
iPLA2 [20]) were employed, and BFA, but neither A23187 nor
leukotriene D4, increased ALP activity in the apical medium by
about 50% (Fig. 4A). The increase by BFAwas abolished by the addition
of either MAFP or BEL (Fig. 4B). BEL is a speciﬁc iPLA2 inhibitor,
suggesting that iPLA2 plays a role in such processes during the
exposure to BFA. Neither BEL nor MAFP had any signiﬁcant effect on
ALP release by Caco-2 cells.
3.5. Inhibition of phospholipase A2 reduces membrane-raft-mediated
Inﬂuenza A virus budding and ﬁssion
The Inﬂuenza A virus utilizes membrane-rafts to assemble its
particles and bud off from host cells [21]. If PLA2 activity is necessary
to modulate the shape of membrane-raft domains, inhibition of PLA2activity should result in the loss of budding. To test this hypothesis, an
Inﬂuenza A virus (H1N1)-infected MDCK cell culture was used to
evaluate the effect of PLA2 inhibitors on the resulting virus titers in the
culture supernatants. Both BEL (iPLA2 inhibitor) andMAFP (cPLA2 and
iPLA2 inhibitor) reduced the virus titer by less than 10%, indicating
that inhibition of iPLA2 was sufﬁcient to block the budding (Fig. 5).
MβCD, which is known to promote incomplete virus particle
production, also reduced the virus titer by less than 10%. No
appreciable toxicity was observed with these three reagents, as
determined by LDH release and MTT assay (data not shown).
4. Discussion
The results of the present study showed that (a) ALP was released
from the brush borders by lysophospholipids, which was abolished by
MβCD, a membrane-raft disrupter; (b) BFA-stimulated ALP release
was blocked by iPLA2 inhibition; (c) the inhibition of iPLA2 also
blocked Inﬂuenza A virus production from MDCK cells; and (d)
endogenously added lysosphingomyelin, a hydrolysis product of
Fig. 4. (A) Brefeldin A (BFA) increases alkaline phosphatase release. The addition of BFA increased ALP release by approximately 1.5-fold, while neither ionomycin nor leukotriene D4
(LTD4), cPLA2 activators, showed such effects. Data are shown as mean and S.E.M. of triplicate assays. (B) Increase in ALP release by BFA was blocked by PLA2 inhibitors. BEL,
bromoenol lactone; MAFP, methyl arachidonyl ﬂuorophosphonate. Data are shown as mean and S.E.M. of triplicate assays. ⁎⁎, pb0.01.
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releasing effect. These ﬁndings suggest that cells utilize inverted corn-
shaped lysophospholipids generated by endogenous or exogenousFig. 5. Inhibition of iPLA2 reduces virus budding. The addition of either BEL (iPLA2
speciﬁc inhibitor) or MAFP (cPLA2 and iPLA2 inhibitor) reduced the virus titer in the
medium, indicating that the inhibition of iPLA2 was sufﬁcient for the reduction in virus
titer. MβCD was used as a positive control. Data are shown as mean and S.E.M. of
triplicate assays.PLA2 to stimulate or initiate outward bending that promotes budding
raft-associated plasma membrane particles.
Brush border hydrolases undergo more rapid turnover (10–15 h)
than cell migration (24–46 h). Although the physiological role of the
faster turnover is still undetermined, it is likely to increase the
digestive ability in the intestinal lumen. The patterns andmechanisms
of enzyme release are different frommolecule to molecule; pancreatic
proteases release high-molecular weight proteins [22], while bile salt
and cholesystokinin/secretin injection release ALP into the lumen
[23,24]. Moreover, fat meal ingestion induces greater increases in
intestinal-type ALP activity in the intestinal lumen and the circulation
[25,26], in which conditions lysoPC should be increased over 2–
4 mmol/l in the lumen. Phospholipase D is thought to mediate GPI-
anchored protein release, but the presence of lysoPC is sufﬁcient for
the release of ALP. The increased luminal concentration of lysoPC by
hydrolysis of biliary phospholipids by pancreatic PLA2 is probably
associated with the rapid turnover by releasing ALP and presumably a
group of brush border enzymes. Inverted corn-shaped lysopho-
spholipids speciﬁcally mediated this release (Fig. 1C), which was
abolished by MβCD. Considering the fact that lysoPC promotes
budding and ﬁssion of raft-domains from artiﬁcial giant liposomes
[9,10], the present results indicate that membrane-rafts are released
from brush borders when enterocytes are exposed to luminal lysoPC.
Membrane-raft budding and ﬁssion might be one of the regulatory
mechanisms for membrane protein compositions through endocyto-
sis or exocytosis by controlling PLA2 activity and the resulting levels of
lysophospholipids.
Both endogenous and exogenous lysophospholipids seemed to
mediatemembrane-raft ﬁssion outside the cells. Thismay be achieved
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membrane. In fact, lysophospholipids are thought to diffuse into the
outer leaﬂet of the plasma membrane, translocate to the inner leaﬂet,
and are then acylated to produce phospholipids or metabolized to
other lipids in the small intestine [27]. Increased lysophospholipid
levels in the plasma membrane also probably promote non-bilayer
structures that could facilitate bilayer mixing. Thus, even the
lysophospholipids produced inside the plasma membrane may be
able to modulate the physico-chemical properties of the outer leaﬂet
membrane probably by increasing local areas of membrane ﬂuidity.
On the other hand, Hansen et al. [17] showed that luminal lysoPC may
induce the rapid endocytosis of brush border ALP by adding bile salt-
mixed lipids digested by pancreatic juice. Lipid absorption is thought
to accompany ALP transcytosis, but another possibility is that lysoPC
contained in the additives might induce membrane-raft ﬁssion into
the intracellular space (endocytosis).
iPLA2, but not cPLA2 [28], is now considered to play an important
role in the secretory process of a number of proteins and lysosomes
taking place by increasing cellular lysoPC concentration [29 and
references therein]. BEL, a speciﬁc iPLA2 inhibitor, could block BFA-
stimulated ALP release; suggesting that activation of iPLA2 triggered
the release process. The lack of increased ALP release by LTD4 or
A233187 [19], both activators of cPLA2, supports the above hypoth-
esis. Indeed, iPLA2 is responsible for the phospholipid remodeling of
the plasma membrane by generating lysophospholipids, which serve
as acceptors for arachidonic acid [30]. Fatty acids are the other
product by PLA2 hydrolysis and formerly considered mediators of
intestinal ALP release [26]. We examined this possibility in the same
model [5], but did not ﬁnd any effect with oleic acid. Furthermore, the
addition of lysophospholipids was sufﬁcient to induce ALP release.
These observations indicate that endogenous or PLA2-generated fatty
acids are not involved in the releasing mechanism.
Membrane-rafts function as microdomains for concentrating viral
glycoproteins and serve as a platform of virus budding [31]. Virus bud
formation requires membrane bending at the budding site, in which
M1 components plays a critical role; however, how host components
facilitate bud completion remains unclear. Treatment of host cells
with MβCD, a membrane-raft disrupter, results in incomplete virus
particle production [21]. In the present study, we conﬁrmed this effect
by the reduced virus titer, and found that Inﬂuenza A virus budding
was blocked by the inhibition of iPLA2 (Fig. 5), supporting the present
idea on the involvement of iPLA2 in membrane-raft budding.
The three approaches were done to examine membrane-raft
budding in living cells, providing consistent ﬁndings. However, the
iPLA2 enzyme group has diverse biological functions; thus, inhibition
of iPLA2 by BEL might generate other dysfunctions in the cells tested,
although toxicity was not detected by MTT assays or LDH release.
Alternative pathways for the titer-reducing effect of BEL were not
examined. Moreover, if incomplete virus formation occurred in the
presence of BEL, biological determination of virus particles would
have underestimated the number of viruses in the medium.
Biological membranes in living cells are now considered as
heterogeneous or clustered membranes that undergo remodeling
continuously by ﬁssion, fusion, or microtubule membrane extension.
The driving force for the dynamic changes and the regulatory
mechanisms are still to be elucidated. It is interesting to speculate
that iPLA2 is involved in these mechanisms by generating lysoPC.
Enveloped RNA viruses include pathogens with exceptional histories
of morbidity, such as human immunodeﬁciency and Inﬂuenza viruses.
The budding of virus particles is the last, but critically important step,
in the virus life cycle for both the survival of the virus as well as its
disease-producing ability in the host. Given that iPLA2 is involved in
the mechanism for virus budding, iPLA2 might provide an interesting
target for antiviral therapy.
In conclusion, the results of the present study suggest that cells
utilize inverted corn-shaped lysophospholipids generated by iPLA2 tomodulate plasma membrane structure and promote the budding of
membrane-raft-associated plasma membrane particles. Moreover,
iPLA2 might be involved in membrane-raft mediated virus budding
and/or ﬁssion processes by generating membrane curvature, suggest-
ing the possibility of iPLA2 acting as a therapeutic target for certain
viral infections.
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